Advanced Enzymes Technologies Ltd.

Wilmington, Delaware, United States: Enzymes are biocatalysts and highly specialized for accelerating various types of chemical reactions without undergoing self-changes. Specialty enzymes are used for special purposes in low volume and high value added applications. These enzymes are currently employed in various applications in DNA manipulation, research and biotechnology, etc. There are many types of specialty enzymes available used for diverse specialty applications which includes proteases, polymerases and nucleases, carbohydrases, lipases, dehydrogenase, and oxidases. According to the research report, the global specialty enzymes market is expected to be worth US$3,726.4 mn by the end of 2025 from US$1,782.0 mn in 2016. The report projects that the global market is likely to rise at a CAGR of 8.7% between 2017 and 2025. Usage of specialty enzymes has resulted in reduced costs of DNA sequencing and manipulation, which has been a significant driver for the market. This factor has played a major role in bolstering the demand for specialty enzymes in areas of biotechnology, research and diagnostic applications. Biocatalysts are used in the production of pharmaceuticals and other fine chemicals; they are included in specialty enzymes due to their relatively low volume use and high value-added nature. Overall demand for biocatalysts is expected to increase at a strong pace, as drug and chemical manufactures continue to search for biocatalysts as alternate methods of production looked to overcome rising production costs. Request Brochure of Report - Research and Biotechnology Provide Global Specialty Enzyme Market a Significant Impetus On the basis of application, the global market is segmented into research and biotechnology, diagnostics, and other specialty. Of these, the research and biotechnology segment is expected to soar at a CAGR of 8.7% between 2017 and 2025. The growing investments in research and development and biotechnologies such as DNA sequencing, immunological assays, detection of RNA, molecular testing, tissue dissociation, and others have led to higher adoption of these enzymes. The report indicates that widening applications are likely to open up newer avenues for growth in the coming years. On the other hand, the diagnostics application segment is also likely to tread a positive path with increasing focus on developing accurate diagnostic tools. Get COVID-19 Analysis on Specialty Enzyme Market - North America to Remain Dominant in Global Market with Technological Advancements By geography, global specialty enzymes market has been segmented into major five region: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2016, North America and Europe accounted for the largest share of the global specialty enzymes market. The U.S. dominated the specialty enzymes market in North America, accounting for around 89.8% share in 2016. This dominance is majorly due factors such technological advancements in biotech & research with rising demand of enzymes, extensive R&D practices and increasing use of enzymes by pharmaceutical companies, rising awareness of enzymes as nutraceuticals are driving market growth. However, Europe is saturated and growing at slow steady rate while Asia is anticipated to witness the fastest CAGR during the forecast period with major contribution of countries such as India, Japan and China. New product launches with broaden applications, favorable regulations, and growing awareness are likely to drive the market in Asia Pacific during the forecast period. Make an Enquiry Before Buying - The key players operating in the specialty enzymes market are Novozymes A/S, Amano Enzymes Inc., Codexis Inc., Advanced Enzymes Technologies Ltd., Affymetrix Inc., BBI Solutions, Roche CustomBiotech, Biocatalysts Ltd. and Amicogen Inc. The global specialty enzymes market is dominated only by few players that operates global market. More Trending Reports by Transparency Market Research – CINV Existing and Pipeline Drugs Market: Controlled Substance Market: Erythropoietin Drugs Market: Chondroitin Sulfate Market: Thin Film Drug Manufacturing Market: Clinical Decision Support System Market: Atrial Fibrillation Market: Hearing Aids Market: About Us Transparency Market Research is a global market research firm offering the latest market research reports and business consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Us Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website:

Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Proteinase K Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Form, By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global proteinase K market size is predicted to reach US$ 107.5 Million by 2027 The report "Proteinase K Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Infectious diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Neurology, and Others); By Form (Powder, and Liquid), By Regions; Segment Forecast, 2020-2027" gives a detailed insight into current market dynamics and provides analysis on future market growth. The global proteinase K demand is anticipated to grow owing to the increasing prevalence of COVID-19 cases, establishment of universities and government-funded laboratories, population-based studies, and innovations in bio-catalysts. Furthermore, the rising number of designated laboratories which perform western blotting, polymerase chain reaction, and in in-vitro research studies is expected to drive market demand for proteinase K. The increasing market demand for proteinase K for pre-treatment of COVID-19 infections is expected to drive product demand. Furthermore, the increasing demand for point of care diagnostics and the growing utility of proteinase K in PoC is expected to drive market demand. In addition, the use of proteinase K for in situ hybridization is likely to complement the proteinase K industry growth. Segment Highlights The infectious diseases segment accounted for the largest revenue share in 2019 owing to the sudden spike in viral infections associated with COVID-19. In addition, the increasing demand for proteinase K for treatment of several infections is likely to complement market growth. Based on form, the proteinase K powdered segment is projected to constitute almost half of the market by the end of 2027. The segment holds the major market share due to its stability in the powered form and it is easy transport. North America accounted for the largest revenue market share in 2019. This can be attributed to sudden spike in COVID-19 infections, presence of key manufacturers in the market, and the government-sponsored population-based studies boosting the consumption of proteinase K. List of Key Players Merck KGaA BBI Solutions Codexis, Inc. SBS Genetech Ltd. Hoffmann-La Roche Ltd Amicogen Amano Enzyme Inc. Advanced Enzymes Technologies Ltd Key Topics Covered: 1. Introduction 2. Executive Summary 3. Research Methodology 4. Proteinase K Market Insights 4.1. Proteinase K - Industry snapshot 4.2. Proteinase K Market Dynamics 4.2.1. Drivers and Opportunities 4.2.1.1. Varied applications in in-vitro diagnostics 4.2.1.2. Sudden spike in COVID-19 cases 4.2.2. Restraints and Challenges 4.2.2.1. Presence of Substitutes 4.3. Porter's Five Forces Analysis 4.4. PESTLE Analysis 4.5. Proteinase K Market Industry trends 5. Proteinase K Market Assessment by Therapeutic Area 5.1. Key Findings 5.2. Introduction 5.3. Infectious diseases 5.4. Diabetes 5.5. Oncology 5.6. Cardiology 5.7. Nephrology 5.8. Autoimmune diseases 5.9. Neurology 6. Global Proteinase K Market, by Form 6.1. Key Findings 6.2. Introduction 6.3. Powder 6.4. Liquid 7. Proteinase K Market Assessment by Geography 7.1. Key findings 7.2. Introduction 7.2.1. Proteinase K Market Assessment, By Geography, 2016-2027 (USD Million) 8. Competitive Landscape 8.1. Expansion and Acquisition Analysis 8.1.1. Expansion 8.1.2. Acquisition 8.2. Partnerships/Collaborations/Agreements/Exhibitions Chapter 9. Company Profiles 9.1. Company Overview 9.2. Financial Performance 9.3. Product Benchmarking 9.4. Recent Developments Merck KGaA BBI Solutions Codexis Inc. SBS Genetech Ltd. F. Hoffmann-La Roche Ltd Amicogen Amano Enzyme Inc. Advanced Enzymes Technologies Ltd Biocatalysts Ltd Dyadic International Affymetrix American Laboratories For more information about this report visit CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Vancouver, British Columbia, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The global dairy enzymes market is projected to reach a market size of USD 999.8 Million by 2027 and register a CAGR of 7.2% during the forecast period, according to latest analysis by Emergen Research. High growth of the market can be attributed to increasing demand for cheese products with refined texture and flavor. Increasing urbanization and rising purchasing power of consumers in developing economies is driving demand for processed dairy products. Development of the dairy industry globally is another factors expected to drive the dairy enzymes market during the forecast period. Increasing investments in research and development activities by major market players for development of innovative dairy enzymes is also expected to propel market growth in the near future. Issues related to allergies due to consumption of dairy products among lactose intolerant consumers is projected to restrain demand for dairy products and in turn restrain market growth to a certain extent. Lactose is broken down into simple sugars, and such products are not advised for consumption by diabetics as it can increase blood glucose levels, and hence demand from this consumer base is expected to be limited. These are some factors expected to hamper demand for such products, and in turn impact market growth during the forecast period. Claim Your FREE Sample Copy with Table of content@ Companies Profiled in this Report are: DuPont, Kerry Group, Chr Hansen Holding A/S, DSM, Advanced Enzymes Technologies, Connell Bros., Novozymes A/S, Biocatalysts Ltd., Amano Enzyme, and SternEnzym Key Highlights of Report In November 2019, DuPont Nutrition & Biosciences launched its new flagship dairy enzyme i.e. DuPont Danisco Nurica. This flexible enzyme enables dairy product manufacturers fermented dairy products that are high in fiber, low in sugar, and lactose-free. The cheese segment held the largest market share of 33.7% in 2019. Rising demand for processed dairy products among consumers with increased purchasing power is expected to drive demand for dairy enzymes to produce enhanced flavored cheese over the next few years. The microbial rennet segment is revenue is expected to expand at the highest CAGR of 8.1% during the forecast period. Cheese-manufacturing companies widely utilize microbial milk-clotting enzymes produced by Rhizomucor pusillus and Rhizomucor miehei. This factor is expected to drive revenue growth of this segment during the forecast period. The Asia Pacific market is expected to expand at the most rapid rate during the forecast period. Growing urbanization in developing economies and rising purchasing power of consumers in the region is driving demand for processed dairy products the market in Asia Pacific. Check Our Prices@ Emergen Research has segmented the global dairy enzymes market in terms of application, type, and region: Application Outlook (Revenue, USD Million; 2017–2027) Cheese Milk Yoghurt Infant Formula Ice Cream & Desserts Others Type Outlook (Revenue, USD Million; 2017–2027) Chymosin Lipase Lactase Microbial Rennet Others (Catalases and Proteases) Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: Regional Outlook (Revenue, USD Million; 2017–2027) North America U.S. Canada Europe Germany U.K. France BENELUX Rest of Europe Asia Pacific China Japan South Korea Rest of APAC Latin America Brazil Rest of LATAM Middle East & Africa Saudi Arabia UAE Rest of MEA Take a Look at our Related Reports: Food Tech Market By Technology Type (Mobile App, Websites), By Service Type (Online Food Delivery, Online Grocery Delivery, OTT & Convenience Services), By Product Type (Meat, Fruits and Vegetables, Dairy), and By Region, Forecasts to 2027 Pet Food Packaging Market By Types of Material (Paper & Paperboard, Plastics, Metals), By Packaging Type (Cans, Pouches, Bags, Cartons), By Animal Type (Dog, Cat, Fish, Bird), and By Regions, Forecasts to 2027. Food Certification Market By Application (Processed Meat & Poultry, Organic Food, Dairy Products, Seafood, Beverages, Infant Food, Others), By Type (ISO 22000, Halal, Kosher, SQF, FSSAI, BRC, Others), By Risk (Low Risk, High Risk), and By Region, Forecasts to 2027 About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: Direct Line: +1 (604) 757-9756 E-mail: sales@emergenresearch.com Facebook | LinkedIn | Twitter | Blogs Read Full Press Release@